- Home
- PROF vs NVX Comparison
PROF vs NVX Comparison
Compare PROF & NVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROF
- NVX
- Stock Information
- Founded
- PROF N/A
- NVX 2012
- Country
- PROF Canada
- NVX Australia
- Employees
- PROF N/A
- NVX N/A
- Industry
- PROF Medical/Dental Instruments
- NVX Industrial Machinery/Components
- Sector
- PROF Health Care
- NVX Miscellaneous
- Exchange
- PROF Nasdaq
- NVX Nasdaq
- Market Cap
- PROF 149.7M
- NVX 169.3M
- IPO Year
- PROF N/A
- NVX N/A
- Fundamental
- Price
- PROF $5.90
- NVX $1.02
- Analyst Decision
- PROF Strong Buy
- NVX
- Analyst Count
- PROF 2
- NVX 0
- Target Price
- PROF $11.50
- NVX N/A
- AVG Volume (30 Days)
- PROF 43.9K
- NVX 63.3K
- Earning Date
- PROF 08-07-2025
- NVX 01-01-0001
- Dividend Yield
- PROF N/A
- NVX N/A
- EPS Growth
- PROF N/A
- NVX N/A
- EPS
- PROF N/A
- NVX N/A
- Revenue
- PROF $11,862,000.00
- NVX $5,854,424.00
- Revenue This Year
- PROF $71.17
- NVX $66.66
- Revenue Next Year
- PROF $134.25
- NVX $2,366.64
- P/E Ratio
- PROF N/A
- NVX N/A
- Revenue Growth
- PROF 75.01
- NVX N/A
- 52 Week Low
- PROF $3.90
- NVX $0.81
- 52 Week High
- PROF $11.42
- NVX $2.73
- Technical
- Relative Strength Index (RSI)
- PROF 49.59
- NVX 38.20
- Support Level
- PROF $5.84
- NVX $1.02
- Resistance Level
- PROF $6.22
- NVX $1.10
- Average True Range (ATR)
- PROF 0.45
- NVX 0.06
- MACD
- PROF -0.09
- NVX -0.01
- Stochastic Oscillator
- PROF 6.28
- NVX 14.29
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
About NVX NOVONIX Limited American Depository Shares
NOVONIX Ltd operates in the lithium-ion battery industry. The company has three operating segments namely Graphite Exploration, Battery Technology, and Battery Materials. Graphite Exploration segment is engaged in the exploration and development of high-grade flake graphite deposits. The Battery Technology segment develops battery cell testing equipment and carries out research and development in battery development. The Battery Materials segment develops and manufactures battery anode materials. The Battery Technology segment generates maximum revenue for the company.